• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Clarivate (CLVT) Reports New Guidance, Is The Stock Still Cheap?

    Simply Wall St·11/04/2026 01:36:18
    Listen to the news

    Clarivate (CLVT) just paired a fresh third quarter loss with new revenue and earnings guidance for the fourth quarter and full year 2026, giving investors clearer numbers to reassess expectations.

    The guidance drop has arrived just as Clarivate’s share price has swung sharply higher in the short term, with a 1-day share price return of 25.9% and a 30-day share price return of 41.22%. However, the longer record tells a very different story, with the 1-year total shareholder return down 39.94% and the 5-year total shareholder return down 91%, so recent momentum appears more like a rebound from heavy losses than a firmly established trend.

    Scan Clarivate’s rebound in context by lining it up against a hand-picked 34 high quality undervalued stocks that also pairs pressured share prices with updated guidance and fresh earnings numbers.

    Clarivate has already staged a sharp bounce, although guidance still points to ongoing losses and pressured revenue. Is the recent 40%+ swing a small step in a longer rerating, or has most of the easy upside already gone as the valuation resets?

    Most Popular Clarivate Narrative: 30% Undervalued

    Clarivate is trading at $2.09 against a widely followed fair value estimate of $2.97, so the narrative framework currently points to meaningful upside relative to that model and sets a high bar for the turnaround story to deliver.

    Rapid expansion and adoption of AI-driven product innovation across all segments (including new AI-powered analytics in Web of Science, Derwent, and Cortellis) enhances product differentiation and workflow integration, driving higher pricing, customer retention, and potentially expanding gross margins.

    Shift to a subscription-focused, recurring SaaS revenue model, evidenced by discontinuing transactional sales and increased subscription mix, provides greater revenue visibility and stability while supporting margin expansion via operational efficiency.

    See why 5 investors see Clarivate as 30% undervalued.

    That story sits on a specific valuation spine. The most followed narrative uses a discount rate of 13.58% and arrives at a fair value estimate of $2.97 per share, compared with Clarivate’s last close at $2.09 and an analyst consensus price target of $2.97. The same framework assumes revenue will decline around 6.9% a year over the next three years, that profit margins eventually move from a loss of $334.0 million toward earnings of $133.8 million by around 2029, and that the stock could trade on a future P/E multiple of 18.8x if those earnings materialise.

    Analysts feeding into this narrative are not expecting Clarivate to reach profitability in the next three years, and they see revenue trending lower rather than higher over that period, even as the model uses a higher future earnings multiple of 18.8x compared with a current implied P/E of 3.9x on today’s loss making base. On top of that, the narrative expects the share count to shrink by roughly 3.29% a year for three years, and it discounts those future cash flows and earnings back to today using the 13.58% rate, which is relatively demanding for a services provider with declining revenue and continuing losses.

    The result is a valuation lens that embeds both repair work and risk. To agree with the popular narrative at $2.97, you would need to be comfortable with revenue at $2.0b by 2029, earnings of $133.8 million, and the idea that the market would pay 18.8x those earnings, all while Clarivate works through declining near term sales and ongoing losses. That fair value also sits within a wider analyst range, from a low of $2.00 to a high of $5.50, which shows there is limited agreement on how quickly the rebuilding effort and AI push can reshape the financial profile.

    Result: Fair Value of $2.97 (UNDERVALUED)

    Still, Clarivate’s reliance on pressured higher education budgets and the risk that free or Open Access data undercuts paid research platforms could quickly weaken that 30% undervalued story.

    Find out about the key risks to this Clarivate narrative.

    Next Steps

    Feeling mixed about Clarivate after all that, or starting to form a view but want more concrete evidence? Move quickly and sift through the 3 key rewards and 2 important warning signs.

    Looking for more investment ideas beyond Clarivate?

    If Clarivate has caught your attention, do not stop there. The screener can surface other opportunities with different risk profiles and return drivers.